Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes
Daisuke Koya(Kanazawa Medical University), Ryuichi Kikkawa(Shiga University of Medical Science), D. Kirk Ways(Eli Lilly (United States)), Haruhisa Sato(Rakuwakai Otowa Hospital), Toshiro Sugimoto(Shiga University of Medical Science), Atsunori Kashiwagi(Shimane University), Masakazu Haneda(Institute for Advanced Study), Shiro Maeda(Shiga University of Medical Science), Hiroko Nakagawa(Nagoya University), George L. King(Joslin Diabetes Center), Hitoshi Yasuda(Kobe Material Testing Laboratory (Japan)), Keiji Isshiki(Shiga University of Medical Science)
Cited by 427
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979